| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 2616 |
| 1 | DIVALPROEX SODIUM | 371 |
| 2 | OLANZAPINE | 251 |
| 3 | CYCLOPHOSPHAMIDE | 245 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 245 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 245 |
| 6 | LORAZEPAM | 219 |
| 7 | QUETIAPINE | 217 |
| 8 | CLONAZEPAM | 215 |
| 9 | VALPROATE SODIUM | 205 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZTROPINE | 183 | 0.0246 |
| 1 | PRIMAQUINE PHOSPHATE | 2 | 0.0230 |
| 2 | FLUPHENAZINE DECANOATE | 10 | 0.0230 |
| 3 | CLOZAPINE | 2616 | 0.0207 |
| 4 | ZIPRASIDONE | 38 | 0.0105 |
| 5 | VALPROATE SODIUM | 205 | 0.0097 |
| 6 | DIVALPROEX SODIUM | 371 | 0.0079 |
| 7 | ZIPRASIDONE HCL | 16 | 0.0060 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 48 | 0.0057 |
| 9 | DAUNORUBICIN HYDROCHLORIDE | 9 | 0.0055 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 2828 |
| 1 | Benzodiazepine [EPC] | 492 |
| 2 | Corticosteroid [EPC] | 333 |
| 3 | Alkylating Drug [EPC] | 311 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 275 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 263 |
| 6 | Osmotic Laxative [EPC] | 247 |
| 7 | Platinum-based Drug [EPC] | 246 |
| 8 | Anti-epileptic Agent [EPC] | 220 |
| 9 | Mood Stabilizer [EPC] | 186 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 2828 | 0.0063 |
| 1 | Typical Antipsychotic [EPC] | 94 | 0.0038 |
| 2 | Actinomycin [EPC] | 8 | 0.0036 |
| 3 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 4 | Adrenal Steroid Synthesis Inhibitor [EPC] | 3 | 0.0030 |
| 5 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 6 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 7 | Provitamin D2 Compound [EPC] | 56 | 0.0019 |
| 8 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 3 | 0.0019 |
| 9 | alpha-Hydroxy Acid [EPC] | 4 | 0.0018 |